Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
grade B 23.46 1.51% 0.35
MGNX closed up 1.51 percent on Tuesday, September 18, 2018, on approximately normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical MGNX trend table...

Date Alert Name Type % Chg
Sep 18 Spinning Top Other 0.00%
Sep 18 Upper Bollinger Band Walk Strength 0.00%
Sep 18 Overbought Stochastic Strength 0.00%
Sep 18 Upper Bollinger Band Touch Strength 0.00%
Sep 17 Slingshot Bullish Bullish Swing Setup 1.51%
Sep 17 Upper Bollinger Band Walk Strength 1.51%
Sep 17 Outside Day Range Expansion 1.51%
Sep 17 Overbought Stochastic Strength 1.51%
Sep 17 Upper Bollinger Band Touch Strength 1.51%
Sep 14 Stochastic Reached Overbought Strength 0.39%

Older signals for MGNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.
Is MGNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.74
52 Week Low 16.12
Average Volume 219,510
200-Day Moving Average 22.3799
50-Day Moving Average 21.1908
20-Day Moving Average 21.7895
10-Day Moving Average 22.247
Average True Range 0.8871
ADX 13.54
+DI 22.9713
-DI 14.0116
Chandelier Exit (Long, 3 ATRs ) 20.9887
Chandelier Exit (Short, 3 ATRs ) 22.0213
Upper Bollinger Band 23.5671
Lower Bollinger Band 20.0119
Percent B (%b) 0.97
BandWidth 16.316116
MACD Line 0.579
MACD Signal Line 0.3726
MACD Histogram 0.2064
Fundamentals Value
Market Cap 863.28 Million
Num Shares 36.8 Million
EPS -4.19
Price-to-Earnings (P/E) Ratio -5.60
Price-to-Sales 56.93
Price-to-Book 2.96
PEG Ratio 0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.35
Resistance 3 (R3) 24.31 23.98 24.20
Resistance 2 (R2) 23.98 23.75 24.00 24.15
Resistance 1 (R1) 23.72 23.62 23.85 23.76 24.10
Pivot Point 23.39 23.39 23.46 23.41 23.39
Support 1 (S1) 23.13 23.16 23.26 23.17 22.82
Support 2 (S2) 22.80 23.03 22.82 22.77
Support 3 (S3) 22.54 22.80 22.72
Support 4 (S4) 22.58